Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 3—March 2010
Perspective

Preparing a Community Hospital to Manage Work-related Exposures to Infectious Agents in BioSafety Level 3 and 4 Laboratories

George F. RisiComments to Author , Marshall E. Bloom, Nancy P. Hoe, Thomas Arminio, Paul Carlson, Tamara Powers, Heinz Feldmann, and Deborah Wilson
Author affiliations: Infectious Disease Specialists, PC, Missoula, Montana, USA (G.F. Risi); St. Patrick Hospital and Health Sciences Center, Missoula (T. Powers); National Institutes of Health, Bethesda, Maryland, USA (G.F. Risi, N.P. Hoe, T. Arminio, P. Carlson, D. Wilson); Rocky Mountain Laboratories, Hamilton, Montana, USA (M.E. Bloom, H. Feldmann)

Main Article

Table 1

BSL-4 laboratories planned or operational, 2009*

Location Status
United States
Centers for Disease Control and Prevention, 
 Atlanta, GA, USA A
Georgia State University Viral Immunology 
 Center, Atlanta A
Boston University National Emerging Infectious 
 Disease Laboratories, Boston, MA, USA NA
United States Army Medical Research Institute 
 of Infectious Diseases, Fort Detrick, MD, USA A
Department of Homeland Security National 
 Biodefense Analysis and Countermeasures 
 Center, Frederick, MD, USA NA
National Institute of Allergy and Infectious 
 Diseases
Integrated Research Facility, Frederick NA
Rocky Mountain Laboratories, Hamilton, MT, 
 USA A
Southwest Foundation for Biomedical Research,
 San Antonio, TX, USA A
University of Texas Medical Branch, Galveston, 
 TX, USA
Robert E. Shope MD BSL-4 Laboratory A
Galveston National Biocontainment 
 Laboratory
 A
Other countries
Geelong, Victoria, Australia A
Winnipeg, Ontario, Canada A
Taiwan NA
London and Salisbury, UK A, A
Lyon, France A
Libreville, Gabon A
Hamburg, Marburg, Berlin, and Greifswald, 
 Germany A, A, A, NA
Pune, India NA
Rome, Italy A
Bilthoven, the Netherlands A
Novosibirsk, Russia A
Sandringham, South Africa NA
Solna, Sweden A
Geneva and Spiez, Switzerland A, NA

*BSL-4, BioSafety Level 4; A, active; NA, nonactive.

Main Article

Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external